PhRMA wins one in California

Share this article:
The Pharmaceutical Research and Manufacturers of America won a victory in last night's elections with the defeat of California Proposition 79, which would have imposed price controls on manufacturers participating in the state's Medi-Cal program and allowed individuals to sue companies for profiteering.
A rival ballot measure, the PhRMA-sponsored Proposition 78, was also voted down, 58-41 percent. PhRMA spent $72 million on an advertising, PR and direct-mail blitz to defeat Proposition 79, which lost by a margin of 61-38 percent. Backed by unions and consumer activists, the measure would have required drug companies to offer steep discounts to the uninsured in order to participate in Medi-Cal. By contrast, Proposition 78 would have encouraged companies to offer discounts voluntarily.
PhRMA's outlay on the campaign included $50 million in media spend and $13 million on glossy mailers, according to California press.
Share this article:
You must be a registered member of MMM to post a comment.
close

Next Article in News

Email Newsletters

More in News

Five things for Pharma Marketers to know: Friday, August 29

Five things for Pharma Marketers to know: Friday, ...

Takeda closes out a good-news, bad-news kind of week, AstraZeneca adds a new clinical trial for its experimental PD-1, and researchers link a funeral to the Ebola outbreak.

Amgen sends PCSK9 to FDA

Amgen sends PCSK9 to FDA

Evolocumab holds the FDA's first filed biologics license application for the class.

Consultants expect M&A tempo to continue

Consultants expect M&A tempo to continue

PwC anticipates that divestitures will fuel late-2014 deals, but notes that the noise around early deals and the financials don't fully match up.